MFDS — authorised 5 May 2014
- Marketing authorisation holder: ASTRAZENECA PHARMS
- Status: likely_approved
🇰🇷 Epanova in South Korea
MFDS authorised Epanova on 5 May 2014
Marketing authorisation
Epanova in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Epanova approved in South Korea?
Yes. MFDS authorised it on 5 May 2014.
Who is the marketing authorisation holder for Epanova in South Korea?
ASTRAZENECA PHARMS holds the South Korean marketing authorisation.